SCHEMBL19122487

SCHEMBL19122487

CC(C)N1CCCC2(COC[C@H]2C)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18705140 0.90 HRH3 (0.31) —
SCHEMBL18705137 0.83 — —
SCHEMBL19756445 0.79 HRH3 (0.31) —
SCHEMBL16984290 0.79 HRH3 (0.31) —
SCHEMBL18705136 0.74 HRH3 (0.36) —
SCHEMBL22306023 0.73 — —
SCHEMBL18705139 0.73 — —
SCHEMBL16659520 0.72 — —
SCHEMBL19734247 0.70 HRH3 (0.30) —
SCHEMBL22008377 0.69 HRH3 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170196862-A2 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2017-07-13 — — US disclosed
Send feedback